Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Tuesday, 16'th Aug 2022
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
AbbVie: Outstanding Portfolio Performance Continues
03:52pm, Monday, 15'th Aug 2022
Skyrizi and Rinvoq are performing exceptionally (expected to deliver $7.5 B sales this year). Neuroscience, aesthetics, and oncology are showing strong growth as well.
AbbVie: Still A Solid Buy After Modeling Sales To 2030
02:40pm, Monday, 15'th Aug 2022
AbbVie's Q2'22 earnings threw up some positives and negatives for investors to contemplate. The Immunology division looks strong, even factoring in the patent cliff faced by $20 billion-selling Humira
Chantico Global CEO Gina Sanchez offers 3 buys and a bail: V, ABBV, DIS & NFLX
12:01am, Saturday, 13'th Aug 2022
Gina Sanchez, Chantico Global CEO, joins 'The Exchange' to discuss her three investment picks for being defensive in the market.
How the Inflation Reduction Act will affect Medicare
01:45pm, Thursday, 11'th Aug 2022
Yahoo Finance's Anjalee Khemlani breaks down the impacts the Inflation Reduction Act could have on Medicare enrollees should Congress pass it.
10 defensive stocks that can also provide you with growth and dividends over the long term
10:05am, Wednesday, 10'th Aug 2022
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
7 Blue-Chip Stocks That Will Survive 2022
10:23am, Tuesday, 09'th Aug 2022
Buying high-quality blue-chip stocks in a bear market could be a solid path to generating lucrative long-term returns. Blue-chip stocks are typically large-cap businesses in the mature stage of their
Buy 4 S&P 500 August Dog Days Dividend Aristocrats
10:15pm, Monday, 08'th Aug 2022
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 65 Aristocrats screened as of August 4, 2022 repre
The 7 Most Undervalued Value Stocks to Buy Now
03:55pm, Monday, 08'th Aug 2022
Value stocks are always a sensible class of equities to consider as an investment. It's all about finding stocks that are believed to be trading below where they should be based on fundamental metrics
Two Appealing Biotech Stocks for Two Distinct investors
11:11am, Monday, 08'th Aug 2022
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
3 Unstoppable Stocks That Don't Care About the Bear Market
09:00am, Sunday, 07'th Aug 2022
When the market is falling, this trio keeps rising.
3 Unstoppable Dividend Stocks to Buy in August
06:08am, Saturday, 06'th Aug 2022
Income investors have a lot to like about these stocks.
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:32am, Friday, 05'th Aug 2022
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
3 Reasons Why AbbVie Stock Could Be Approaching a Make or Break Moment
10:00am, Friday, 05'th Aug 2022
It won't be able to rely on Humira for growth for much longer.
Johnson & Johnson And AbbVie: 2 Great Dividend Aristocrats For What's Coming Next
08:00am, Thursday, 04'th Aug 2022
The 2022 bear market might not be over, with some blue-chip economists predicting a further 18% to 43% decline before we bottom. JNJ and ABBV are two defensive healthcare dividend kings, which are up
